APOTEX INC. — Paclitaxel Importer Profile
Pharmaceutical Importer · #7 buyer for Paclitaxel · $650.0K import value · 13 shipments · CANADA · DGFT Verified
APOTEX INC. is the #7 importer of Paclitaxel from India with $650.0K in import value and 13 verified shipments. APOTEX INC. holds a 0.7% market share in Paclitaxel imports based in CANADA. The company sources from 1 verified supplier across 12 formulations shipped to 1 country. Overall, APOTEX INC. imports 14 pharmaceutical products worth $40.9M across 7 therapeutic categories.
APOTEX INC. — Paclitaxel Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Paclitaxel to APOTEX INC.?
Verified from 13 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| PANACEA BIOTEC PHARMA LIMITED | $650.0K | 13 | 100.0% |
APOTEX INC. sources Paclitaxel from 1 verified Indian supplier based on 13 customs records. The primary supplier is PANACEA BIOTEC PHARMA LIMITED accounting for 100.0% of imports.
How Does APOTEX INC. Compare to Nearest Paclitaxel Importers?
Buyers ranked immediately above and below #7 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | APOTEX CORP | CANADA | $700.0K | 14 | $50.0K |
| 5 | OOOJODAS EXPOIM | RUSSIA | $700.0K | 14 | $50.0K |
| 7 | APOTEX INC. ★ | CANADA | $600.0K | 12 | $50.0K |
| 9 | APOTEX INC ★ | CANADA | $450.0K | 9 | $50.0K |
| 17 | J KNIPPER COMPANY | UNITED STATES | $350.0K | 7 | $50.0K |
APOTEX INC. ranks #7 among 959 Paclitaxel importers from India. Average shipment value of $50.0K compared to the market average of $30.0K. The closest competitors by value are APOTEX CORP and OOOJODAS EXPOIM.
Where Does APOTEX INC. Import Paclitaxel To?
Destination countries from 13 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $650.0K | 13 | 100.0% |
APOTEX INC. imports Paclitaxel to 1 country. The primary destination is CANADA receiving 100.0% of shipments worth $650.0K.
What Paclitaxel Formulations Does APOTEX INC. Import?
| Formulation | Value | Shipments |
|---|---|---|
| PACLITAXEL ( PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSION 100 MG) B/N.907024024 M/D.01/2025 E/D.12/2026. | $100.0K | 2 |
| PACLITAXEL (PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSION 100 MG) B/N.907024001 M/D.05/2024 E/D.04/2026. | $50.0K | 1 |
| PACLITAXEL ( PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSION 100MG) B/N.907024019 M/D.01/2025 E/D.12/2026. | $50.0K | 1 |
| PACLITAXEL ( PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSION 100MG) B/N.907024018 M/D.12/2024 E/D.11/2026. | $50.0K | 1 |
| PACLITAXEL ( PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSION 100MG) B/N.907024020 M/D.01/2025 E/D.12/2026. | $50.0K | 1 |
| PACLITAXEL ( PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSION 100MG) B/N.907024016 M/D.12/2024 E/D.11/2026. | $50.0K | 1 |
| PACLITAXEL ( PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSION 100MG) B/N.907024022 M/D.01/2025 E/D.12/2026. | $50.0K | 1 |
| PACLITAXEL ( PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSION 100MG) B/N.907024021 M/D.01/2025 E/D.12/2026. | $50.0K | 1 |
| PACLITAXEL ( PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSION 100 MG) B/N.907024026 M/D.01/2025 E/D.12/2026. | $50.0K | 1 |
| PACLITAXEL ( PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSION 100 MG) B/N.907024023 M/D.01/2025 E/D.12/2026. | $50.0K | 1 |
APOTEX INC. imports 12 distinct Paclitaxel formulations from India. The top formulation is PACLITAXEL ( PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSIO with 2 shipments worth $100.0K.
Regulatory Requirements: Importing Paclitaxel into Canada
What APOTEX INC. and other importers must comply with to import Paclitaxel from India
Regulatory Authority
Health Canada (HC)
Approval Process for Generic Paclitaxel
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
GMP Requirements
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
Import Licence & Documentation
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Labeling & Packaging
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Paclitaxel from India and How Much Does APOTEX INC. Import?
India exported $28.7M worth of Paclitaxel through 4,928 shipments from 319 suppliers to 142 countries, serving 959 buyers globally. APOTEX INC. imports $650.0K of this total, accounting for 0.7% of India's Paclitaxel exports with 13 shipments from CANADA. This is verified from 13 customs shipment records covering 12 distinct formulations.
What Is the Average Order Value for APOTEX INC.'s Paclitaxel Imports?
APOTEX INC.'s average Paclitaxel order value is $50.0K per consignment, based on 13 shipments totaling $650.0K. APOTEX INC. is based in CANADA and ranks #7 among all Paclitaxel importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Paclitaxel to APOTEX INC.?
APOTEX INC. sources Paclitaxel from 1 verified Indian supplier: PANACEA BIOTEC PHARMA LIMITED ($650.0K, 100.0%). This is based on 13 customs records.
How Does APOTEX INC. Compare to Other Paclitaxel Importers?
APOTEX INC. ranks #7 among 959 Paclitaxel importers from India with a 0.7% market share. The top 3 importers are FRESENIUS KABI DEUTSCHLAND GMBH ($17.2M), J. KNIPPER & COMPANY ($1.9M), MERMISI LLC ($1.1M). APOTEX INC. processed 13 shipments from CANADA.
About APOTEX INC.
APOTEX INC. imports 14 products worth $40.9M. Beyond Paclitaxel, top products include Apixaban, Fluticasone, Atorvastatin, Amino, Acetaminophen. View the complete APOTEX INC. profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Paclitaxel — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Paclitaxel shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: APOTEX INC. matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as APOTEX INC.'s capped import value divided by total capped export value for Paclitaxel across all Indian exporters.
- 5.Verified Records: This page is backed by 13 individual customs records matching APOTEX INC. importing Paclitaxel, covering 12 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 142+ countries, 959+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Paclitaxel Import Data for APOTEX INC.
Access order-level details, pricing data, supplier connections, and competitive analysis for APOTEX INC.'s Paclitaxel imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
APOTEX INC.
Full Company Profile →
14 products · $40.9M total trade · 7 categories
APOTEX INC. × Paclitaxel
Verified from customs records
Company Overview
Top Products by APOTEX INC.
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for APOTEX INC..
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Paclitaxel. For current order-level data, contact TransData Nexus.